These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 33839449)

  • 1. Examining brief and ultra-brief anxiety and depression screening methods in a real-world epilepsy clinic sample.
    Munger Clary HM; Wan M; Conner K; Brenes GA; Kimball J; Kim E; Duncan P; Snively BM
    Epilepsy Behav; 2021 May; 118():107943. PubMed ID: 33839449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultra-short screening instruments for major depressive episode and generalized anxiety disorder in epilepsy: The NDDIE-2 and the GAD-SI.
    Micoulaud-Franchi JA; Bartolomei F; McGonigal A
    J Affect Disord; 2017 Mar; 210():237-240. PubMed ID: 28064112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid detection of generalized anxiety disorder and major depression in epilepsy: Validation of the GAD-7 as a complementary tool to the NDDI-E in a French sample.
    Micoulaud-Franchi JA; Lagarde S; Barkate G; Dufournet B; Besancon C; Trébuchon-Da Fonseca A; Gavaret M; Bartolomei F; Bonini F; McGonigal A
    Epilepsy Behav; 2016 Apr; 57(Pt A):211-216. PubMed ID: 26994447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychometric properties of the Lithuanian version of the NDDI-E in persons with epilepsy and suicidal ideation.
    Puteikis K; Mameniškienė R
    Epilepsy Behav; 2022 Nov; 136():108913. PubMed ID: 36155364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychiatric comorbidities among people with epilepsy: A population-based assessment in disadvantaged communities.
    Goel P; Singh G; Bansal V; Sharma S; Kumar P; Chaudhry R; Bansal N; Chaudhary A; Sharma S; Sander JW
    Epilepsy Behav; 2022 Dec; 137(Pt A):108965. PubMed ID: 36343531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. German translation and validation of the brief Epilepsy Anxiety Survey Instrument (brEASI).
    Michaelis R; Schlömer S; Popkirov S; Krämer G; Lindemann A; Cosentino M; Reuber M; Heinen G; Wellmer J; Grönheit W; Wehner T; Schlegel U; Scott AJ; Gandy M
    Epilepsy Behav; 2022 Sep; 134():108857. PubMed ID: 35907288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced rates of detection and treatment of depression and anxiety disorders among adult patients with epilepsy using automated EMR-based screening.
    Fox J; Wood MF; Phillips SE; Crudele A; Haas KF; Abou-Khalil BW; Sonmezturk HH
    Epilepsy Behav; 2021 Oct; 123():108259. PubMed ID: 34418639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the generalized anxiety disorder-7 in people with epilepsy: a MEPSY study.
    Seo JG; Cho YW; Lee SJ; Lee JJ; Kim JE; Moon HJ; Park SP
    Epilepsy Behav; 2014 Jun; 35():59-63. PubMed ID: 24798411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does It Matter What Screener We Use? A Comparison of Ultra-brief PHQ-4 and E-mwTool-3 Screeners for Anxiety and Depression Among People With and Without HIV.
    Basaraba CN; Stockton MA; Sweetland A; Medina-Marino A; Lovero KL; Oquendo MA; Greene MC; Mocumbi AO; Gouveia L; Mello M; Dos Santos P; Suleman A; Mabunda D; Mandlate F; Xavier A; Fumo W; Massinga L; Khan S; Feliciano P; Kann B; Salem AF; Bezuidenhout C; Mootz JJ; Duarte CS; Cournos F; Wall MM; Wainberg ML
    AIDS Behav; 2023 Apr; 27(4):1154-1161. PubMed ID: 36209180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Patient Health Questionnaire-9 (PHQ-9) for depression screening in adults with epilepsy.
    Rathore JS; Jehi LE; Fan Y; Patel SI; Foldvary-Schaefer N; Ramirez MJ; Busch RM; Obuchowski NA; Tesar GE
    Epilepsy Behav; 2014 Aug; 37():215-20. PubMed ID: 25064739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Who is willing to participate in research? A screening model for an anxiety and depression trial in the epilepsy clinic.
    Munger Clary HM; Croxton RD; Allan J; Lovato J; Brenes G; Snively BM; Wan M; Kimball J; Wong MH; O'Donovan CA; Conner K; Jones V; Duncan P
    Epilepsy Behav; 2020 Mar; 104(Pt A):106907. PubMed ID: 32000099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for epilepsy-specific anxiety symptoms: French validation of the EASI.
    Micoulaud-Franchi JA; Kotwas I; Arthuis M; Soncin L; Rontani P; Daquin G; Cermolacce M; Bartolomei F; McGonigal A
    Epilepsy Behav; 2022 Mar; 128():108585. PubMed ID: 35180578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing severity of comorbid psychiatric symptoms in an epilepsy clinic using a colocation model: results of a pilot intervention.
    Chen JJ; Caller TA; Mecchella JN; Thakur DS; Homa K; Finn CT; Kobylarz EJ; Bujarski KA; Thadani VM; Jobst BC
    Epilepsy Behav; 2014 Oct; 39():92-6. PubMed ID: 25238553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined detection of depression and anxiety in epilepsy patients using the Neurological Disorders Depression Inventory for Epilepsy and the World Health Organization well-being index.
    Hansen CP; Amiri M
    Seizure; 2015 Dec; 33():41-5. PubMed ID: 26556677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between the Neurological Disorders Depression Inventory for Epilepsy and the Patient Health Questionnaire-9 in patients with epilepsy according to antiepileptic drug load.
    Kim HJ; Jeon JY; Kim HW; Lee SA
    Seizure; 2020 Jan; 74():14-19. PubMed ID: 31775100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Not always that EASI: Validating the Russian version of the epilepsy anxiety survey instrument and its brief counterpart.
    Zinchuk M; Kustov G; Pashnin E; Gersamia A; Rider F; Voinova N; Popova S; Sviatskaia E; Yakovlev A; Guekht A
    Epilepsy Behav; 2022 Aug; 133():108801. PubMed ID: 35753109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A population study comparing screening performance of prototypes for depression and anxiety with standard scales.
    Christensen H; Batterham PJ; Grant JB; Griffiths KM; Mackinnon AJ
    BMC Med Res Methodol; 2011 Nov; 11():154. PubMed ID: 22103584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for depression in people with epilepsy: comparative study among neurological disorders depression inventory for epilepsy (NDDI-E), hospital anxiety and depression scale depression subscale (HADS-D), and Beck depression inventory (BDI).
    de Oliveira GN; Lessa JM; Gonçalves AP; Portela EJ; Sander JW; Teixeira AL
    Epilepsy Behav; 2014 May; 34():50-4. PubMed ID: 24681386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining the psychometric properties of brief screening measures of depression and anxiety in chronic pain: The Patient Health Questionnaire 2-item and Generalized Anxiety Disorder 2-item.
    Bisby MA; Karin E; Scott AJ; Dudeney J; Fisher A; Gandy M; Hathway T; Heriseanu AI; Staples L; Titov N; Dear BF
    Pain Pract; 2022 Apr; 22(4):478-486. PubMed ID: 35258171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptom network analysis of anxiety and depression in epilepsy.
    Gauld C; Bartolomei F; Micoulaud-Franchi JA; McGonigal A
    Seizure; 2021 Nov; 92():211-215. PubMed ID: 34600300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.